| Trans Fatty Acids and Cardiovascular Disease |
| | Competing interests |
|
| www.notransfatnyc.org |
| | Outline of presentation |
|
| Factory workers needed bread en butter |
| | You cannot put cottonseed oil on bread.. |
|
| 1902: Wilhelm Norman patents the hardening of edible oils through hydrogenation |
| | Partial hydrogenation gave food manufacturers control over the properties of a major food ingredient |
|
| A polyunsaturated fatty acid: linoleic acid |
| | Hydrogenation converts essential polyunsaturated fatty acids into saturated and trans fatty acids |
|
| Saturated fats stack up like planks in a stack of wood, creating hard fats. |
| | Why food manufacturers like the trans fat in partially hydrogenated oils |
|
| Partially hydrogenated cottonseed oil |
| | Outline of presentation |
|
| In 1990 Mensink & Katan showed that trans fat lowers HDL and raises LDL |
| | Effect of trans and saturated fat on the LDL:HDL ratio in 9 controlled trials |
|
| Trans fatty acids raise the bad cholesterol and lower the good cholesterol, so they ought to increase the risk of heart disease. Do they? |
| | Risk of coronary heart disease as a function of industrial trans fat intake in prospective studies |
|
| Trans fat and cardiovascular disease: quality of the evidence |
| | Trials of endothelial function as a surrogate for clinical trials |
|
| Measurement of arterial diameter |
| | Flow-mediated dilation after cuff release is a measure of endothelial ‘health’ |
|
| Trans fat impairs endothelial-dependent vasodilation in volunteers |
| | Effects of trans fats on lipids and flow-mediated dilation are consistent with associations with CHD |
|
| “Pleiotropic” effects of trans fat |
| | Why is the ‘effect’ in epidemiology larger than predicted from the effect on lipids? |
|
| Outline of presentation |
| | The two sources of trans fat |
|
| Saturated and trans fatty acids in Dutch margarines, 1980-1996 |
| | Saturated and trans fatty acids in Dutch frying fats, 1980-2004 |
|
| Trans fat intake in the 1960s and 2006 |
| | Sources of trans fat in the Dutch diet |
|
| Trans fat intake has plunged |
| | Effect of conjugated linoleic acid on lipoproteins in healthy humans |
|
| Why study CLA? |
| | “Animal” trans fatty acids: uncertainties |
|
| Conjugated Linoleic Acid: a ruminant trans fatty acid sold as a weight loss supplement |
| | Objective |
|
| Design of CLA trial |
| | Controlled dietary intervention |
|
| Effect of industrial and ‘natural’ trans fat on blood lipids relative to oleic acid |
| | Dosis of trans fat and ΔLDL/HDL in published trials of industrial and animal trans fat |
|
| What would vaccenic acid do to the LDL/HDL ratio? |
| | Conclusions |
|
| Thank you for your attention |
| | Unsaturated fatty acids in native triglycerides have kinks and there is rotation around the kinks |
|
| So unsaturated triglycerides will not stack and therefore remain liquid |
| | Hydrogenation changes the melting properties of triglycerides |
|
| Saturated and trans-unsaturated fatty acids are straight and allow triglycerides to crystallize |
| | The Gap: Predicted effect on heart disease risk of reducing trans intake by 2 energy% (~ 5 gram/d) |
|
| Why is there a gap? |
| | Cis- and trans isomers and nomenclature |
|
| Distribution of trans fatty acid isomers in milk and industrial fats |
| | How different is natural trans from industrial trans? |
|
Deel deze pagina met collega's en vrienden: